The ADP ribosylation factor GTPase-activating protein 1 (ARFGAP1) has been reported to inhibit cell growth through mTORC1 signaling and is a prognostic factor of overall survival in pancreatic cancer patients [36]. This evidence concerns the gene ARFGAP1 and familial pancreatic carcinoma.